ArticleNature communications2015

Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling.

Gina L Zoratti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.